Home › Funds › Redmile Group, LLC › ZYME

Redmile Group, LLC position in ZYME

ZYMEWORKS INC · Health Care

Redmile Group, LLC reported holding 491,654 shares of ZYME (ZYMEWORKS INC) in its Q2 2026 13F filing — a position valued at US$12.9M, representing 0.86% of its reported portfolio and ranking #24 among its reported holdings. Redmile Group, LLC has disclosed ZYME holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)491.65K sh
Reported value held$12.85M
Portfolio Weight0.86%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Redmile Group, LLC's ZYME position evolved

Redmile Group, LLC first disclosed a stake in ZYME in Q3 2023 at 5,661,230 shares (US$35.9M). The position peaked in Q4 2024 at 4,840,463 shares, worth US$70.9M. Across 12 filings, Redmile Group, LLC increased the stake 1 time(s), trimmed it 8 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 491,654 shares valued at US$12.9M. Notable position changes include a 87% trim in Q4 2025 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 5.66M $35.89M New
Q4 2023 5.79M $60.16M Add
Q1 2024 5.56M $58.50M Reduce
Q2 2024 5.21M $44.35M Reduce
Q3 2024 5.10M $64.03M Reduce
Q4 2024 4.84M $70.86M Reduce
Q1 2025 4.79M $57.04M Reduce
Q2 2025 4.15M $52.09M Reduce
Q3 2025 3.71M $63.29M Reduce
Q4 2025 491.65K $12.95M Reduce
Q1 2026 491.65K $12.31M Hold
Q2 2026 491.65K $12.85M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZYME and 13F data

ZYME (ZYMEWORKS INC) is a Health Care company. 30 other funds we track also report a position in ZYME — the largest reported positions include EcoR1 Capital, LLC (US$600.4M), Rubric Capital Management LP (US$183.0M), PERCEPTIVE ADVISORS LLC (US$109.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZYME

All ZYME fund holders →

FAQ

How long has Redmile Group, LLC held ZYME?

Redmile Group, LLC has disclosed ZYME holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Redmile Group, LLC's current position in ZYME?

As of Q2 2026, Redmile Group, LLC holds 491.65K shares of ZYME (ZYMEWORKS INC), valued at $12.85M, representing 0.86% of its reported portfolio and ranking #24.

Has Redmile Group, LLC been buying or selling ZYME?

In the latest 13F filing (Q2 2026), Redmile Group, LLC held unchanged its position in ZYME. The position peaked in Q4 2024 at 4.84M shares.

Which other funds hold ZYME?

Other major institutional holders of ZYME include EcoR1 Capital, LLC, Rubric Capital Management LP, PERCEPTIVE ADVISORS LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.